Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Halliburton Company (HAL), C.R. Bard, Inc. (BCR), Microsoft Corporation (MSFT): Stocks that Boosted Valueact Capital

Valueact Capital, managed by Jeffrey Ubben finished first quarter ending March 31, 2013 on a high, appreciating by 9.7% after payment of all fees and expenses. Since its inception in 2000, the fund has appreciated by 16.6% on a net annualized basis with key company positions in Halliburton Company (NYSE:HAL), C.R. Bard, Inc. (NYSE:BCR), Microsoft Corporation (NASDAQ:MSFT) and Gardner Denver, Inc. (NYSE:GDI), etc. Recovering global economy has seen an increase in valuation for the likes of Moody’s Corporation (NYSE:MCO) and Gardner Denver, Inc. (NYSE:GDI) by 10% in cash-on-cash valuation.

VALUEACT CAPITAL

During the first quarter of 2013 Value Act Capital realized its investments in Moody’s Corporation (NYSE:MCO), Halliburton Company (NYSE:HAL) and Gardner Denver, Inc. (NYSE:GDI) as well as agreeing to be acquired by KKR in a LBO. Value Act Capital’s investments in Moody’s Corporation (NYSE:MCO) paid off as the company’s earnings and multiple expanded having been bought on the thesis that the Federal Reserve monetary policy of low-interest rates was conducive. The stock of Moody’s Corporation (NYSE:MCO) increased by 67.71% from the beginning of the second quarter of 2013.

Valueact Capital projection on Halliburton Company (NYSE:HAL) meeting supply needs for big new players in North American land production, proved to be correct for the quarter. Halliburton Company (NYSE:HAL) strong stock performance was, on the other hand, impacted by higher valuation on improved psychology for future-upturn in activity. The stock of Halliburton Company (NYSE:HAL) has jumped 73.68% since the first quarter of 2013.

As of the end of the first quarter Valueact Capital had sold approximately $144 million of its position in C.R. Bard, Inc. (NYSE:BCR), a position that was built from 2009 to 2010 at approximately $80 a share. Depressed healthcare spending and changing procurement practices have greatly affected the company’s stock price over the past years. C.R. Bard, Inc. (NYSE:BCR)’s stock has increased by 45.51% from the beginning of the second quarter of 2013.

During the first quarter, Value Act Capital initiated three new investments in the name of MICROS Systems, Inc. (NASDAQ:MCRS), Invensys PLC and Microsoft Corporation (NASDAQ:MSFT). The shares of Microsoft Corporation (NASDAQ:MSFT) surged by 45.72% from the third quarter of 2013.

Valueact Capital took advantage of MICROS Systems, Inc. (NASDAQ:MCRS)’s share price weakness to make an investment in the company after 10 years of following and admiration. The company initiated its position in MICROS Systems, Inc. (NASDAQ:MCRS) at an average cost of $42.73 per share. The stock of MICROS Systems, Inc. (NASDAQ:MCRS) increased by50.02% from July 2013.

Investment in Invensys also follows 5-years of following including holding meetings with current and former CEO’s. Value Act Capital holds a 7% position in Invensys at a cost of 3.40 a share.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!